Association of hypoadiponectinemia with hypoglutathionemia in NAFLD subjects with and without type 2 diabetes

Disease Markers

Volumn 29, Issue 5, 2010, Pages 213-221

  Sandhya, Narasimhan ^a   Gokulakrishnan, Kuppan ^a   Ravikumar, Radhakrishnan ^a   Mohan, Viswanathan ^a   Balasubramanyam, Muthuswamy ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

adiponectin; glutathione; NAFLD; oxidative stress; Type 2 diabetes

Indexed keywords

ADIPONECTIN; GLUTATHIONE; RECOMBINANT PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENDER; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPOADIPONECTINEMIA; HYPOGLUTATHIONEMIA; LIVER CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PARAMETER; PRIORITY JOURNAL; PROTEIN CARBONYLATION; STANDARD; ULTRASOUND;

EID: 79951532297     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0743     Document Type: Article

References (51)

1. F. Angulo, NAFLD, obesity and bariatric surgery, Gastroen-terology 130 (2006), 1848-1852.
2. J.H. Koh, Y.G. Shin, S.M. Nam, M.Y. Lee, C.H. Chung and J.Y. Shin, Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients, Diabetes Care 32 (2009), 147-152.
3. V. Mohan, S. Farooq, M. Deepa, R. Ravikumar and C.S. Pitcu-moni, Prevalence of Non-alcoholic fatty liver disease in urban South Indians in relation to different grades of glucose intolerance and metabolic syndrome, Diabetes Res Clin Pract 84 (2009), 84-91.
4. Y. Kamada, T. Takehara and N. Hayashi, Adipocytokines and liver disease, J Gastroenterol 43 (2008), 811-822.
5. C.M. Bergamini, S. Gambetti, A. Dondi and C. Cervellati, Oxygen, reactive oxygen species and tissue damage, Curr Pharm Des 10 (2004), 1611-1626. (Pubitemid 38559774)
6. A.J. Sanyal, S.C. Campbell, F. Mirshahi, W.B. Rizzo, M.J. Contos, R.K. Sterling et al., Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities, Gastroenterology 120 (2001), 1183-1192. (Pubitemid 32246672)
7. N. Chalasani, M.A. Deeg and D.W. Crab, Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with non-alcoholic steatohepatitis, Am J Gastroen-terol 99 (2004), 1497-1502. (Pubitemid 39193189)
8. Z. Yesilova, H. Yaman, C. Oktenli, A. Ozcan, A. Uygun, E. Cakir et al., Systemic markers of lipid peroxidation and antioxidants in patients with non-alcoholicfatty liver disease, Am J Gastroenterol 100 (2005), 850-855. (Pubitemid 40592378)
9. E. Tsochatzis, G.V. Papatheodoridis and A.J. Archimandritis, The evolving role of leptin and adiponectin in chronic liver diseases, The American Journal of Gastroenterology 101 (2006), 2629-2640. (Pubitemid 44665263)
10. V. Mohan, R. Deepa, R. Pradeepa, K.S. Vimaleswaran, A. Mohan, K. Velmurugan and V. Radha, Association of low adiponectin levels with the metabolic syndrome - the Chennai Urban Rural Epidemiology Study (CURES-4), Metabolism 54 (2005), 476-481. (Pubitemid 40410448)
11. T.Schraw, Z.V. Wang, N.Halberg, M. Hawkins and P.E. Scherer, Plasma adiponectin complexes have distinct biochemical characteristics, Endocrinology 149 (2008), 2270-2282. (Pubitemid 351574488)
12. Y. Matsuzawa, The metabolic syndrome and adipocytokines, FEBS Lett 580 (2006), 2917-2921. (Pubitemid 43729162)
13. M. Liu, L. Zhou, A. Xu, K.S. Lam, M.D. Wetzel, R. Xiang, J. Zhang, X. Xin, L.Q. Dong and F. Liu, A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization, Proc Natl Acad Sci U S A 105 (2008), 18302-18307.
14. M. Deepa, R. Pradeepa, M. Rema, A. Mohan, R. Deepa, S. Shanthirani et al., The Chennai Urban Rural Epidemiology Study (CURES) - Study Design and Methodology (Urban Component) (CURES - 1), J Assoc Physicians India 51 (2003), 863-870. (Pubitemid 41279865)
15. K.G. Alberti and P.Z. Zimmet, Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation, Diabet Med 15 (1998), 539-553. (Pubitemid 28319935)
16. K. Yagi, A simple fluorometric assay for lipoperoxide in blood plasma, Biochem Med 15 (1976), 212-216.
17. R.L. Levin, D. Garlan, C.N. Oliver, A. Amici, I. Clement and A.G. Lenz, Determination of carbonyl content in oxidatively modified proteins, Methods Enzymol 186 (1990), 464-478. (Pubitemid 20279989)
18. R. Sampath Kumar, M. Balasubramanyam, C. Tara, M. Rema and V. Mohan, Association of hypoglutathionemia with reduced Na+/K+ activity in type 2 diabetes and microangiopa-thy, Mol cell Biochem 282 (2006), 169-176. (Pubitemid 43019475)
19. A.E. Joseph, S.H. Saverymuttu, S. Al-sam, M.G. Cook and J.D. Maxwell, Comparison of liver histology with ultrasonog-raphy in assessing diifuse parenchymal liver disease, Clin Ra-diol 43 (1991), 26-31.
20. A. Lonardo, M. Bellimni, P. Tartoni and E. Tondelli, The bright liver syndrome. Prevalence and determinants of a bright liver ECHO pattern, Ital J gastroenterol Hepatol 29 (1997), 351-356. (Pubitemid 28059513)
21. K. Madan, P. Bhardwaj, S. Thareja, S.D. Gupta and A. Saraya, Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD), A J Clin Gastroenterol 40 (2006), 930-935. (Pubitemid 44690769)
22. K.S. Das, V. Balakrishnan, S. Mukherjee and D.M. Vasude-van, Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease, Scand J Clin Lab Invest 68 (2008), 323-334. (Pubitemid 351962413)
23. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani and K. Wakasa, In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases, J Hepatol 37 (2002), 56-62. (Pubitemid 34713055)
24. A. Adaikalakoteswari, M. Balasubramanyam and V. Mohan, Telomere shortening occurs in Asian Indian Type 2 diabetic patients, Diabet Med 22 (2005), 1151-1156. (Pubitemid 41224172)
25. L.A. Videla, R. Rodrigo, J. Araya and J. Poniachik, Oxidative stress and depletion of hepatic polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease, Free Radic Biol Med 37 (2004), 1499-1507. (Pubitemid 39349251)
26. C.M. Kusminski and P.E. Scherer, The road from discovery to clinic: adiponectin as a biomarker of metabolic status, Clin Pharmacol Ther 86 (2009), 592-595.
27. U.B. Pajvani, M. Hawkins, T.P. Combs, M.W. Rajala, T. Doeb-ber, J.P. Berger, J.A. Wagner, M. Wu, A. Knopps, A.H. Xiang, K.M. Utzschneider, S.E. Kahn, J.M. Olefsky, T.A. Buchanan and P.E. Scherer, Complex distribution, not absoluteamount of adiponectin, correlates with thiazolidinedione-mediated im- provement in insulin sensitivity, J Biol Chem 279 (2004), 12152-12162. (Pubitemid 38445780)
28. A.H. Berg, T.P. Combs, X. Du, M. Brownlee and P.E. Scher-er, The adipocyte-secreted protein Acrp30 enhances hepatic insulin action, Nat Med 7 (2001), 947-953. (Pubitemid 32756433)
29. M. You and C.Q. Rogers,Adiponectin: a key adipokine in alcoholic fatty liver, Exp Biol Med (Maywood) 234 (2009), 850-859.
30. G.L. Tipoe, C.T. Ho, E.C. Liong, T.M. Leung, T.Y. Lau, M.L. Fung and A.A. Nanji, Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD), Histol Histopathol 24 (2009), 1161-1169.
31. C. Aygun, O. Senturk, S. Hulagu, S. Uraz, A. Celebi, T. Kon-duk, B. Mutlu and Z. Canturk, Serum levels of hepatopro-tective peptide adiponectin in non-alcoholic fatty liver disease, European Journal of Gastroenterology & Hepatology 18 (2006), 175-180. (Pubitemid 43361603)
32. A. Adaikalakoteswari, M. Balasubramanyam, M. Rema and V. Mohan, Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy, Diabet Med 23 (2006), 666-674. (Pubitemid 43830069)
33. R. Sampathkumar, M. Balasubramanyam, S. Sudarslal, M. Rema, V. Mohan and P. Balaram, Increased glutathionylat-ed hemoglobin (HbSSG) in type 2 diabetes subjects with mi-croangiopathy, Clin Biochem 38 (2005), 892-899. (Pubitemid 41319684)
34. A. Adaikalakoteswari, M. Rema, V. Mohan and M. Bala-subramanyam, Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy, Int J Biochem Cell Biol 39 (2007), 1673-1684. (Pubitemid 47088311)
35. K. Gokulakrishnan, K.T. Mohanavalli, F. Monickaraj, V. Mohan and M. Balasubramanyam, Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and Type 2 diabetes patients, Mol Cell Biochem 324 (2009), 173-181.
36. M. Brownlee, The pathobiology of diabetic complications, Diabetes 54 (2005), 1615-1625.
37. P.E. Scherer, Adipose tissue: from lipid storage compartment to endocrine organ, Diabetes 55 (2006), 1537-1545. (Pubitemid 44324105)
38. C.S. Lieber, M.A. Leo, K.M. Mak, Y. Xu, Q. Cao, C. Ren et al., Model of nonalcoholic steatohepatitis, Am J Clinical Nutrition 79 (2004), 502-509. (Pubitemid 41115597)
39. M. Hori, K. Oniki, T. Nakagawa, K. Takata, S. Mihara, T. Marubayashi et al., Association between combinations of glutathione-S-transferase M1, T1 and P1 genotypes and nonalcoholic fatty liver disease, Liver Int 29 (2009), 164-168.
40. M. Liu and F. Liu, Transcriptional and post-translational regulation of adiponectin, Biochem J 425 (2009), 41-52.
41. D.B. Briggs, C.M. Jones and E.H. Mashalidis, Nuñez M, Hausrath AC, Wysocki VH, Tsao TS. Disulfide-dependent self-assembly of adiponectin octadecamers from trimers and presence ofstable octadecameric adiponectin lacking disulfide bonds in vitro, Biochemistry 48 (2009), 12345-12357.
42. G. Wolf, New insights into thiol-mediated regulation of adiponectin secretion, Nutr Rev 66 (2008), 642-645.
43. F. Piemonte, S. Petrini, L.M. Gaeta, G. Tozzi, E. Bertini, R. Devito et al., Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease, J Gastroenterol Hepatol 23 (2008), 457-464.
44. S. Plant, B. Shand, P. Elder and R. Scott, Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins, Diab Vasc Dis Res 5 (2008), 102-108. (Pubitemid 351839281)
45. S.L. Prior, D.R. Gable, J.A. Cooper, S.C. Bain, S.J. Hurel, S.E. Humphries and J.W. Stephens, Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus, Eur Heart J 30 (2009), 1263-1269.
46. C. Iwata, X. Wang, K. Uchida, N. Nakanishi and Y. Hattori, Buthionine sulfoximine causes endothelium dependent hyper-relaxation and hypoadiponectinemia, Life Sci 80 (2007), 873-878. (Pubitemid 46149858)
47. J. Fukushima, Y. Kamada, H. Matsumoto, Y. Yoshida, H. Eza-ki, T. Takemura, Y. Saji, T. Igura, S. Tsutsui, S. Kihara, T. Funahashi, I. Shimomura, S. Tamura, S. Kiso and N. Hayashi, Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization, Hepatol Res 39 (2009), 724-738.
48. T. Matsunami, Y. Sato, S. Ariga, T. Sato, H. Kashimura, Y. Hasegawa and M. Yukawa, Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis, Int J Clin Exp Pathol 22 (2010), 472-481.
49. A. Gastaldelli, S. Harrison, R. Belfort-Aguiar, J. Hardies, B. Balas, S. Schenker and K. Cusi, Pioglitazone in the treatment of NASH: the role of adiponectin, Aliment Pharmacol Ther (2010), in press.
50. J.F. Landrier, E. Gouranton, C. El Yazidi, C. Malezet, P. Bal-aguer, P. Borel and M.J. Amiot, The fact that Adiponectin ex-pressionis induced by vitamin Evia aperoxisome proliferator-activated receptor gamma-dependent mechanism, Endocrinology 150 (2009), 5318-5325.
51. P. Detopoulou, D.B. Panagiotakos, C. Chrysohoou, E. Fragopoulou, T. Nomikos, S. Antonopoulou, C. Pitsavos and C. Stefanadis, Dietary antioxidant capacity and concentration of adiponectin in apparently healthy adults: the ATTICA study, Eur J Clin Nutr 64 (2010), 161-168.